Marsh McLennan (MRSH) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
5 Nov, 2025Executive summary
Revenue for Q2 2025 grew 12% year-over-year to $7.0B, with underlying revenue up 4%, driven by business momentum and acquisitions, notably McGriff.
Adjusted operating income increased 14% to $2.1B, and adjusted EPS rose 11% to $2.72; GAAP EPS was $2.45.
For the first six months, revenue was $14.0B (up 11%), adjusted operating income $4.3B (up 11%), and adjusted EPS $5.78 (up 8%).
The macro environment remains uncertain, with risks from geopolitics, litigation, and rapid AI development impacting clients and operations.
Announced a 10% dividend increase to $0.90 per share, marking 16 consecutive years of dividend growth.
Financial highlights
Q2 2025 consolidated revenue reached $7.0B (up 12%); adjusted operating margin was 29.5%, up 50 basis points year-over-year.
Q2 net income attributable was $1.2B; Q2 operating income was $1.8B (up 11%).
For the first six months, operating income was $3.8B (up 7%), and net income was $2.6B.
Quarterly dividend increased 10% to $0.90; $600M in share repurchases completed in H1 2025.
Operating cash flow for H1 2025 was $1.05B, up from $434M in H1 2024.
Outlook and guidance
Expecting mid-single-digit underlying revenue growth, solid adjusted EPS growth, and 18th consecutive year of margin expansion for 2025.
Capital deployment for 2025 projected at $4.5B across dividends, acquisitions, and share repurchases.
McGriff acquisition expected to be modestly accretive to adjusted EPS in 2025, more so in 2026 and beyond.
Management highlights ongoing macroeconomic and geopolitical risks as potential headwinds.
New U.S. tax legislation and OECD global minimum tax rules are not expected to materially impact results.
Latest events from Marsh McLennan
- 2025 revenue up 10%, adjusted EPS up 9%, and $2.0B in share repurchases.MRSH
Q4 202527 Feb 2026 - Q2 revenue up 6%, EPS up 10%, margin 29%, and dividend raised 15% amid robust growth.MRSH
Q2 20243 Feb 2026 - Q3 revenue up 6%, strong segment growth, and $7.75B McGriff acquisition announced.MRSH
Q3 202419 Jan 2026 - Strong 2024 growth, record acquisitions, and margin expansion set up a positive 2025 outlook.MRSH
Q4 20249 Jan 2026 - Q1 2025 revenue up 9%, adjusted EPS up 5%, with strong segment growth and capital returns.MRSH
Q1 202519 Dec 2025 - Strong 2024 results, robust governance, and key votes on directors, pay, auditor, and equity plan.MRSH
Proxy Filing1 Dec 2025 - Annual meeting to vote on directors, pay, auditor, and incentive plan, all board-backed.MRSH
Proxy Filing1 Dec 2025 - Q3 revenue up 11%, adjusted EPS up 11%, Thrive targets $400M savings, rebranding to Marsh.MRSH
Q3 202520 Oct 2025